References
- DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, . Expanded GGGGCC hexanucleotide repeat in non-coding region of C9orf72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245–56.
- Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, . A hexanucleotide repeat expansion in C9orf72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257–68.
- Majounie E, Renton AE, Mok K, Dopper EGP, Waite A, Rollinson S, . Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012:11:323–30.
- Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, . Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population based cohort study. Lancet Neurol. 2012;11:232–40.
- Chio A, Borghero G, Restagno G, Mora G, Drepper C, Traynor BJ, . Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGCC hexanucleotide repeat expansion of C9orf72. Brain. 2012:135:784–93.
- Millecamps S, Boillee S, Le Ber I, Seilhean D, Teyssou E, Giraudeau M, . Phenotype difference between ALS patients with expanded repeats in C9orf72 and patients with mutations in other ALS-related genes. J Med Genet. 2012;49:258–63.
- Simon-Sanchez J, Dopper EGP, Cohn-Hokke PE, Hukema RK, Nicolaou N, Seelaar H, . The clinical and pathological phenotype of C9orf72 hexanucleotide repeat expansions. Brain. 2012;135:723–35.
- Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AMT, . Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9orf72 mutations. Brain. 2012;135:693–708.
- Dobson-Stone C, Hallupp M, Bartley L, Shepherd CE, Halliday GM, Schofield PR, . C9orf72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts. Neurology. 2012;79:995–1001.
- Snowden JS, Thompson JC, Stopford CL, Richardson AMT, Gerhard A, Neary D, . The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships. Brain. 2011;134:2478–92.
- Goldman JS, Farmer JM, Wood EM, Johnson JK, Boxer A, Neuhaus J, . Comparison of family histories in FTLD subtypes and related tauopathies. Neurology. 2005;65: 1817–9.
- Mackenzie IRA, Neumann M, Bigio E, Cairns NJ, Alafuzoff I, Kril J, . Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol. 2009;117:15–8.
- Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, . Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. An update. Acta Neuropathol. 2010;119:1–4.
- Mackenzie IRA, Neumann M, Baborie A,Sampathu, DM, Du Plessis D, Jaros E, . A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 2011;122: 111–3.
- McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend Med. 2010;7:557–70.
- Rosso SM, Donker Kaat L, Baks T, Joosse M, de Konig I, Pijnenburg Y, . Frontotemporal dementia in the Netherlands: patient characteristics and prevalence estimates. Brain. 2003;126:2016–22.
- Raaphorst J, Beeldman E, de Visser M, de Haan RJ, Schmand B. A systematic review of the behavioural changes in motor neuron disease. Amyotroph Lateral Scler. 2012;13:493–501.
- Lillo P, Garcin B, Hornberger M, Bak TH, Hodges JR. Neurobehavioural features in frontotemporal dementia with amyotrophic lateral sclerosis. Arch Neurol. 2011;67:826–30.
- Katz JS, Katzberg HD, Woolley SC, Marklund SL, Andersen PM. Combined fulminant frontotemporal dementia and amyotrophic lateral sclerosis associated with an I113T SOD1 mutation. Amyotroph Lateral Scler. 2012;13:567–9.